miR-221/222: promising biomarkers for breast cancer

MicroRNAs (miRNAs) are small noncoding RNAs of 19–25 nt that can regulate gene expression at a posttranscriptional level. Increasing evidence indicates that miRNAs participate in almost every step of cellular processes and are often aberrantly expressed in human cancer. miR-221 and miR-222 are two highly homologous miRNAs that always act as a gene cluster (miR-221/222) in cellular regulation and have extensively been studied in cancer network. Here, we review the role of miR-221/222 in breast cancer (BCa) development and progression: regulating proliferative signaling pathways, altering telomere and telomerase activity, avoiding cell death from tumor suppressors, autophagy and apoptosis, monitoring angiogenesis, supporting epithelial–mesenchymal transition, and even controlling cell-specific function within microenvironment. We consider that miR-221/222 act as promising biomarkers for BCa and they would offer a new way in molecular targeting cancer treatment.

[1]  C. Croce,et al.  MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. , 2010, Journal of the National Cancer Institute.

[2]  Susmita Datta,et al.  Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells. , 2011, Cancer letters.

[3]  W. Durán,et al.  The NO cascade, eNOS location, and microvascular permeability. , 2010, Cardiovascular research.

[4]  G. Hannon,et al.  A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases , 2008, Nature Structural &Molecular Biology.

[5]  R. Dahiya,et al.  MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer , 2010, Cancer Prevention Research.

[6]  M. Rugge,et al.  Correction: Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma , 2012, BMC Cancer.

[7]  C. J. Barnes,et al.  Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  Francesca Orso,et al.  microRNA-222 Controls Neovascularization by Regulating Signal Transducer and Activator of Transcription 5A Expression , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[9]  N. Miller,et al.  Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer , 2009, Breast Cancer Research and Treatment.

[10]  A. Cheung,et al.  Telomere dysfunction, genome instability and cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[11]  C. Heldin,et al.  Regulation of EMT by TGFβ in cancer , 2012, FEBS letters.

[12]  Maria Kafousi,et al.  MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer , 2011, Cell cycle.

[13]  M. Bushell,et al.  microRNAs in cancer management. , 2012, The Lancet. Oncology.

[14]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[15]  P. Tarapore,et al.  Estrogen receptor-beta and breast cancer: Translating biology into clinical practice , 2012, Steroids.

[16]  Chunxiang Zhang,et al.  Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. , 2012, Journal of molecular and cellular cardiology.

[17]  A. Lal,et al.  MicroRNAs and their target gene networks in breast cancer , 2010, Breast Cancer Research.

[18]  Preclinical S Tudy.  Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs , 2012 .

[19]  Stefanie Dimmeler,et al.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.

[20]  C. Croce,et al.  miR221/222 in cancer: their role in tumor progression and response to therapy. , 2012, Current molecular medicine.

[21]  F. Guo,et al.  Caspases cleave and inhibit the microRNA processing protein DiGeorge Critical Region 8 , 2012, Protein science : a publication of the Protein Society.

[22]  Jia Luo,et al.  Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells. , 2012, Cancer research.

[23]  M. Rugge,et al.  Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. , 2012, BMC cancer.

[24]  J. Thiery,et al.  SnapShot: The Epithelial-Mesenchymal Transition , 2011, Cell.

[25]  S. Lowe,et al.  miR-221 overexpression contributes to liver tumorigenesis , 2009, Proceedings of the National Academy of Sciences.

[26]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[27]  D. Noonan,et al.  Inflammation, inflammatory cells and angiogenesis: decisions and indecisions , 2008, Cancer and Metastasis Reviews.

[28]  Mikhail Pachkov,et al.  MicroRNA-221–222 Regulate the Cell Cycle in Mast Cells1 , 2009, The Journal of Immunology.

[29]  Soonhag Kim,et al.  Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle. , 2012, Biomaterials.

[30]  A. Aschrafi,et al.  MicroRNA-338 Regulates Local Cytochrome c Oxidase IV mRNA Levels and Oxidative Phosphorylation in the Axons of Sympathetic Neurons , 2008, The Journal of Neuroscience.

[31]  G. Wakabayashi,et al.  Downregulation of miR‐138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines , 2008, Cancer science.

[32]  C. Kang,et al.  PUMA is a novel target of miR-221/222 in human epithelial cancers. , 2010, International journal of oncology.

[33]  D. Katsaros,et al.  Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome , 2011, Breast Cancer Research.

[34]  D. Seals,et al.  MicroRNA changes in human arterial endothelial cells with senescence: Relation to apoptosis, eNOS and inflammation , 2012, Experimental Gerontology.

[35]  S. Barsky,et al.  ERα signaling through slug regulates E-cadherin and EMT , 2010, Oncogene.

[36]  M. I. Rosa,et al.  Accuracy of telomerase in estimating breast cancer risk: a systematic review and meta-analysis. , 2012, Breast.

[37]  Anton J. Enright,et al.  MiR-221 Influences Effector Functions and Actin Cytoskeleton in Mast Cells , 2011, PloS one.

[38]  A. Neugut,et al.  Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival , 2012, Breast Cancer Research and Treatment.

[39]  W. Keith,et al.  Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. , 2008, Biochimie.

[40]  Meng Li,et al.  MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways , 2011, Oncogene.

[41]  R. García-Becerra,et al.  Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance , 2012, International journal of molecular sciences.

[42]  Giovanni Vanni Frajese,et al.  miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1* , 2007, Journal of Biological Chemistry.

[43]  F. Ishikawa,et al.  Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells. , 2011, Journal of biochemistry.

[44]  George A Calin,et al.  MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer , 2011, Genome Medicine.

[45]  C. Prives,et al.  Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.

[46]  K. Nakayama,et al.  miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. , 2011, Blood.

[47]  Tyler E. Miller,et al.  MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦ , 2008, Journal of Biological Chemistry.

[48]  S. Peiró,et al.  Snail Family Regulation and Epithelial Mesenchymal Transitions in Breast Cancer Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[49]  J. Pyo,et al.  Molecules and their functions in autophagy , 2012, Experimental & Molecular Medicine.

[50]  C. Speyer,et al.  Regulation of the Expression and Activity of the Antiangiogenic Homeobox Gene GAX/MEOX2 by ZEB2 and MicroRNA-221 , 2010, Molecular and Cellular Biology.

[51]  C. J. Barnes,et al.  Human Epidermal Growth Factor Receptor 2 Status Modulates Subcellular Localization of and Interaction with Estrogen Receptor α in Breast Cancer Cells , 2004, Clinical Cancer Research.

[52]  Satoru Takahashi,et al.  Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer , 2011, Breast Cancer Research and Treatment.

[53]  Laura Mariani,et al.  MicroRNAs modulate the angiogenic properties of HUVECs. , 2006, Blood.

[54]  Jordan S. Pober,et al.  Dicer Dependent MicroRNAs Regulate Gene Expression and Functions in Human Endothelial Cells , 2007, Circulation research.

[55]  W. Yuan,et al.  Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration , 2011, Heart.

[56]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[57]  Chunxiang Zhang,et al.  A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia , 2009, Circulation research.

[58]  F. Yu,et al.  Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy , 2011, Oncology Research and Treatment.

[59]  J. Gustafsson,et al.  Differential Recruitment of the Mammalian Mediator Subunit TRAP220 by Estrogen Receptors ERα and ERβ* , 2001, The Journal of Biological Chemistry.

[60]  D. Yee,et al.  MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer , 2010, Hormones & cancer.

[61]  R. Gambari,et al.  Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells , 2012, BMC Cancer.

[62]  A. Lund,et al.  MicroRNA regulation of autophagy. , 2012, Carcinogenesis.

[63]  N. Voirin,et al.  Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype , 2009, British Journal of Cancer.

[64]  Ru-Fang Yeh,et al.  TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2011, Science Signaling.

[65]  C. Kang,et al.  Analysis of miR-221 and p27 expression in human gliomas. , 2009, Molecular medicine reports.

[66]  Hansjuerg Alder,et al.  miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. , 2009, Cancer cell.

[67]  Gian Luca Grazi,et al.  MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality , 2009, Clinical Cancer Research.

[68]  Kotb Abdelmohsen,et al.  microRNA Expression Patterns Reveal Differential Expression of Target Genes with Age , 2010, PloS one.

[69]  E. Howe,et al.  The miR-200 and miR-221/222 microRNA Families: Opposing Effects on Epithelial Identity , 2012, Journal of Mammary Gland Biology and Neoplasia.

[70]  Domenico Coppola,et al.  MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer* , 2008, Journal of Biological Chemistry.

[71]  R. Elkon,et al.  A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility , 2010, Nature Cell Biology.

[72]  R. Gambari,et al.  Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells. , 2012, International journal of oncology.

[73]  Leonard D. Goldstein,et al.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.

[74]  D. Bonatto,et al.  Senescence; an endogenous anticancer mechanism. , 2012, Frontiers in bioscience.

[75]  Stephen T. C. Wong,et al.  Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. , 2012, Cancer research.

[76]  Tyler E. Miller,et al.  Anti-microRNA-222 (Anti-miR-222) and -181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal* , 2011, The Journal of Biological Chemistry.

[77]  Yixuan Hou,et al.  MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer. , 2012, The international journal of biochemistry & cell biology.